Close Menu

Disease Areas

News and analysis on disease research and diagnostics.

The Chicago-based precision medicine software startup raised the funds through a Series A round led by digital health-focused venture capital firm HealthX Ventures.

For the three-month period ended June 30, Cancer Genetics posted total revenues of $1.4 million compared to $1.5 million in the year-ago quarter.

Mission Bio will use a recent $70 million funding round to develop quality control assays using its Tapestri single-cell analysis platform.

The work aims to identify drivers of protective immune responses to the virus, with the goal of using that information to inform therapeutics development.

The Pro-Lab Diagnostic Pro-AmpRT SARS-CoV-2 test consists of six primers and amplifies a 206 base-pair region of the ORF1ab gene of SARS-CoV-2.

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.

Aug
26
Sponsored by
Bionano Genomics

Alzheimer’s disease is genetically complex with no meaningful therapies or pre-symptomatic disease diagnostics. 

Sep
01
Sponsored by
Roche

This webinar will address the utility of exome sequencing for neurodevelopmental disorders research and will provide details of a comparison study of two exome probe kits in this field of study.